MET and AXL activate common downstream signaling pathways, including PI3K/AKT and MAPK/ ERK networks,12, 36, 37 leading to tumor growth, metastasis, drug resistance, immune suppression, and the stem cell phenotype.11, 35, 38. This evidence concerns the gene MET and neoplasm.